|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4950 AUD | -1.98% |
|
-3.88% | -23.85% |
| Market Cap | 143M 101M 87.39M 80.43M 75.45M 142M 9.58B 951M 371M 4.69B 380M 372M 16.24B | P/E Ratio 2026 * |
-6.97x | P/E Ratio 2027 * | -4.56x |
|---|---|---|---|---|---|
| Enterprise Value | 151M 107M 92.37M 85.01M 79.75M 150M 10.13B 1B 393M 4.96B 402M 394M 17.16B | EV / Sales 2026 * |
19.7x | EV / Sales 2027 * | 19.9x |
| Free-Float |
57.05% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -1.98% | ||
| 1 week | -3.88% | ||
| Current month | -10.00% | ||
| 1 month | +3.12% | ||
| 3 months | +4.21% | ||
| 6 months | -17.50% | ||
| Current year | -23.85% |
| 1 week | 0.49 |  | 0.52 |
| 1 month | 0.47 | | 0.59 |
| Current year | 0.42 | | 0.73 |
| 1 year | 0.28 | | 0.73 |
| 3 years | 0.28 | | 0.78 |
| 5 years | 0.28 | | 1.38 |
| 10 years | 0.13 | | 1.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Graham
CEO | Chief Executive Officer | - | 2020-08-27 |
Justin Reynolds
DFI | Director of Finance/CFO | - | - |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 2020-09-29 |
| Director | Title | Age | Since |
|---|---|---|---|
Michele Dilizia
BRD | Director/Board Member | - | 2012-09-30 |
James Graham
BRD | Director/Board Member | - | 2012-04-30 |
| Director/Board Member | - | 2022-08-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02-23 | Expiration | Chief Executive Officer | 2,250,000 | 0.7781% | ||
| 25-10-13 | Expiration | Chief Executive Officer | 745,962 | 0.3217% | ||
| 24-11-20 | Buy | Chairman | 2,650,000 | 1.1429% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.98% | -3.88% | +57.14% | -2.94% | 103M | |
| +0.14% | -1.29% | +39.91% | +152.38% | 1,007B | |
| -0.07% | -0.89% | +51.32% | +43.02% | 567B | |
| +0.30% | -0.99% | +16.94% | +60.99% | 392B | |
| -0.80% | +1.05% | +20.91% | +18.37% | 328B | |
| -0.43% | +1.12% | +24.21% | +31.89% | 277B | |
| +0.64% | -2.55% | +22.80% | +12.69% | 275B | |
| -1.86% | +4.01% | -43.73% | -49.21% | 196B | |
| -0.25% | +1.58% | +18.42% | +52.40% | 189B | |
| +2.27% | +1.40% | +14.82% | +61.37% | 154B | |
| Average | -0.26% | +0.10% | +22.28% | +38.09% | 338.61B | |
| Weighted average by Cap. | -0.08% | -0.03% | +27.46% | +67.87% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.68M 5.44M 4.69M 4.31M 4.05M 7.6M 514M 50.98M 19.92M 252M 20.4M 19.97M 871M | 8.86M 6.28M 5.41M 4.98M 4.67M 8.77M 593M 58.86M 22.99M 290M 23.55M 23.06M 1.01B |
| Net income | -20.45M -14.48M -12.48M -11.49M -10.78M -20.24M -1.37B -136M -53.05M -670M -54.35M -53.2M -2.32B | -30.9M -21.89M -18.86M -17.36M -16.29M -30.6M -2.07B -205M -80.18M -1.01B -82.14M -80.4M -3.51B |
| Net Debt | 8.15M 5.77M 4.98M 4.58M 4.3M 8.07M 546M 54.14M 21.15M 267M 21.66M 21.2M 924M | 33.53M 23.75M 20.47M 18.84M 17.67M 33.2M 2.24B 223M 87M 1.1B 89.13M 87.24M 3.8B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-16 | 0.4950 $ | -1.98% | 81,561 |
| 26-06-15 | 0.5050 $ | +1.00% | 4,797 |
| 26-06-12 | 0.5000 $ | +2.04% | 85,743 |
| 26-06-11 | 0.4900 $ | -4.85% | 188,481 |
| 26-06-10 | 0.5150 $ | +0.98% | 30,225 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RCE Stock
Select your edition
All financial news and data tailored to specific country editions
